Search Results - "Bergesio, F."

Right ventricular function in AL amyloidosis: characteristics and prognostic implication by Cappelli, Francesco, Porciani, Maria Cristina, Bergesio, Franco, Perlini, Stefano, Attanà, Paola, Moggi Pignone, Alberto, Salinaro, Francesco, Musca, Francesco, Padeletti, Luigi, Perfetto, Federico

“…The importance of right ventricle (RV) dysfunction in AL amyloidosis has been underestimated. This study was designed to comprehensively evaluate RV function…”
Get full text

The impact of spleen metabolic tumor volume on total metabolic tumor volume and prognosis in patients with follicular lymphoma enrolled in FOLL 12 trial by Guerra, L., Chauvie, S., Marcheselli, L., Bergesio, F., Durmo, R., Peano, S., Franceschetto, A., Fallanca, F., Pinto, A., Ghiggi, C., Pulsoni, A., Merli, M., Farina, L., Tani, M., Boccomini, C., Musuraca, G., Falini, B., Ballerini, F., Stefani, P., Bolis, S. A. M., Pietrantuono, G., Manni, M., Federico, M., Luminari, S., Versari, A.

Get full text

Prognostic value of the end of induction PET in patients with follicular lymphoma: results from the analysis of FOLL 12 trial by Guerra, L., Bergesio, F., Fallanca, F., Chauvie, S., Marcheselli, L., Durmo, R., Peano, S., Franceschetto, A., Pinto, A., Tani, M., Merli, M., Boccomini, C., Musuraca, G., Pulsoni, A., Falini, B., Ghiggi, C., Farina, L., Ballerini, F., Stefani, P., Bolis, S. A. M., Pietrantuono, G., Manni, M., Federico, M., Luminari, S., Versari, A.

Get full text

The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin’s lymphoma patients—the Polish Lymphoma Research Group (PLRG) Observational Study by Zaucha, J.M., Małkowski, B., Chauvie, S., Subocz, E., Tajer, J., Kulikowski, W., Fijołek-Warszewska, A., Biggi, A., Fallanca, F., Kobylecka, M., Dziuk, M., Woszczyk, D., Rybka, J., Kroll-Balcerzak, R., Bergesio, F., Romanowicz, A., Chamier-Ciemińska, A., Kurczab, P., Giza, A., Leśniewski-Kmak, K., Zaucha, R., Świetlik, D., Wróbel, T., Knopińska-Posłuszny, W., Walewski, J., Gallamini, A.

“…Interim PET after two ABVD cycles (iPET2) predicts treatment outcome in classical Hodgkin’s lymphoma. To test whether an earlier assessment of chemosensitivity…”
Get full text

Clinical utility of circulating tumor DNA qualification and quantification in classical Hodgkin lymphoma by Pirosa, M. C., Bruscaggin, A., Terzi di Bergamo, L., Salehi, M., Spina, V., Pini, K., Bocchetta, S., Giordano, C., Forestieri, G., Condoluci, A., Piffaretti, D., Almeida, J. Marques, Galimberti, G. A., Annunziata, S., Bergesio, F., Boldorini, R., Borsatti, E., Bulian, P., Chauvie, S., Cuzzocrea, M., di Trani, M., Cristaldi, V., Gerber, B., Jauk, F., Kurlapski, M., Larocca, L. M., Moccia, A., Moia, R., Rinaldi, A., Rodari, M., Romanowicz, G., Sacchetti, G. M., Stathis, A., Stüssi, G., Zangrilli, I., Pinto, A., Mazzucchelli, L., Gattei, V., Zaucha, J. M., Hohaus, S., Santoro, A., Carlo‐Stella, C., Gaidano, G., Cavalli, F., Zucca, E., Ceriani, L., Rossi, D.

Get full text

PET scanner clinical trial qualification with 68Ge-filled NEMA/IEC image quality phantom outperforms with respect to 18F by Chauvie, S, Bergesio, F, Fioroni, F, Brambilla, M

Get full text

Application of standardized procedure enhances reliability of SUV data in PET/CT studies by Bergesio, F, Terulla, A, Bertone, E, Chauvie, S

Get full text

INTERIM ANALYSIS OF CENTRAL REVIEW OF END‐OF‐THERAPY PET IN FOLL12 TRIAL FOR FOLLICULAR LYMPHOMA by Guerra, L., Bergesio, F., Versari, A., Franceschetto, A., Peano, S., Fallanca, F., Storto, G., Luminari, S., Rigacci, L., Gallamini, A., Federico, M., Chauvie, S.

Get full text

Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter study by Bonomo, P., Merlotti, A., Morbelli, S., Berti, V., Saieva, C., Bergesio, F., Bacigalupo, A., Belgioia, L., Franzese, C., Lopci, E., Casolo, A., D’Angelo, E., Alterio, D., Travaini, L., Berretta, L., Pirro, V., Ursino, S., Volterrani, D., Roncali, M., Vigo, F., Cicchetti, S., Scalone, F., Belli, G., Cauda, S., Desideri, I., Russi, E., Livi, L., Bianchi, A.

“…Purpose Response assessment to definitive non-surgical treatment for head and neck squamous cell carcinoma (HNSCC) is centered on the role of 18…”
Get full text

Application of LIDEA (LIver DEtection Algorithm) for PET/CT scans by Bertone, E, Bergesio, F, Terulla, A, Cerello, P, Chauvie, S

Get full text

Impact of uptake time in physiological compartments for PET/CT examination by Bergesio, F, Terulla, A, Guerra, D, Bertone, E, Chauvie, S

Get full text

S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA by Pirosa, M. C., Bruscaggin, A., Terzi di Bergamo, L., Salehi, M., Pini, K., Spina, V., Bocchetta, S., Condoluci, A., Forestieri, G., Piffaretti, D., Marques De Almeida, J., Annunziata, S., Bergesio, F., Borsatti, E., Bulian, P., Chauvie, S., Marco, C., Martina, D. T., Bernhard, G., Kurlapski, M., Moccia, A., Moia, R., Rinaldi, A., Rodari, M., Romanowicz, G., Sacchetti, G. M., Stasia, A., Stathis, A., Stüssi, G., Zangrilli, I., Larocca, L. M., Pinto, A., Santoro, A., Cavalli, F., Zucca, E., Gattei, V., Zaucha, J. M., Carlo‐Stella, C., Hohaus, S., Gaidano, G., Ceriani, L., Rossi, D.

Get full text

Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without evident liver involvement. Unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis? by Paudice, N., Farsetti, S., Caroti, L., Ciuti, G., Tempestini, A., Perfetto, F., Bergesio, F.

Get full text

Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis—a collaborative study of the Italian Renal Immunopathology Group by Frascà, Giovanni M., Onetti-Muda, Andrea, Mari, Francesca, Longo, Ilaria, Scala, Elisa, Pescucci, Chiara, Roccatello, Dario, Alpa, Mirella, Coppo, Rosanna, Volti, Giovanni Li, Feriozzi, Sandro, Bergesio, Franco, Schena, Francesco P., Renieri, Alessandra

“…Background. Thin glomerular basement membrane disease (TBMD) is a nephropathy defined by diffuse thinning of the glomerular basement membrane (GBM) at electron…”
Get full text

The Florence Register of amyloidosis: 20 years' experience in the diagnosis and treatment of the disease in the Florence district area by Cania, A., Bergesio, F., Curciarello, G., Perfetto, F., Ciciani, A. M., Nigrelli, S., Minuti, B., Caldini, A. L., Di Lollo, S., Nozzoli, C., Salvadori, M.

Get full text

Renal involvement in systemic amyloidosis : An Italian collaborative study on survival and renal outcome by BERGESIO, F, CICIANI, A. M, SALVADORI, M, MANGANARO, M, PALLADINI, G, SANTOSTEFANO, M, BRUGNANO, R, DI PALMA, A. M, GALLO, M, ROSATI, A, TOSI, P. L

“…Few data are available from large population-based studies on survival and renal outcome of patients with renal involvement and different types of systemic…”
Get full text

SC03.03 THE MEDICAL PHYSICIST: CENTRAL ROLE IN THE PROCEDURE FOR MRI EXAMINATIONS IN PATIENTS WITH ACTIVE IMPLANTED MEDICAL DEVICES by de Maggi, A., Murru, E., Bergesio, F., Roberto, E., Lio, M.E., Bergalla, E., Chauvie, S.

Get full text

CLINICAL TRIAL QUALIFICATION OF PET-CT SCANNERS IN ONCO-HAEMATOLOGICAL CLINICAL TRIALS: A WORLDWIDE EXPERIENCE FROM CUNEO IMAGING CORELAB (CNCL) by Bergesio, F., De Maggi, A., Murru, E., Guerra, L., Chauvie, S.

Get full text

THE SFM: CENTRAL ROLE IN THE PROCEDURE FOR MRI EXAMINATIONS IN PATIENTS WITH IMPLANTED CARDIAC MEDICAL DEVICES by Murru, E., De Maggi, A., Bergesio, F., Lio, M.E., Roberto, E., Chauvie, S.

Get full text

18F FLUORINE PET TRACER DIFFERENT BIODISTRIBUTIONS CAN LEAD TO AN UNDERESTIMATED DOSE TO THIRD PARTY by De Maggi, A., Bergesio, F., Murru, E., Lio, E., Roberto, E., Chauvie, S.

Get full text